Aldeyra Therapeutics Inc (NASDAQ:ALDX)
| 12.26 Delayed Data As of Jan 22 |  +0.47 / +3.99%Today’s Change | 1.48 Today|||52-Week Range 14.62 | +78.72% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 18.8K | 35.8K | 37.8K | 71.0K | ||
| Operating Expenses | Gross Income | -18.8K | -35.8K | -37.8K | -71.0K | |
| General Expenses | 12.0M | 18.7M | 22.5M | 39.6M | ||
| Research And Development | 7.6M | 13.2M | 16.3M | 29.8M | ||
| Total Operating Expenses | 12.0M | 18.7M | 22.5M | 39.7M | ||
| Non-Operating Expenses | Operating Income | -12.0M | -18.7M | -22.5M | -39.7M | |
| Interest Expense On Debt | 112.3K | 105.5K | 113.5K | 146.8K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -12.1M | -18.7M | -22.3M | -38.9M | |
| Net Income | -12.1M | -18.7M | -22.3M | -38.9M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 8.6M | 11.4M | 15.9M | 21.7M | |
| Shares To Calculate EPS Diluted | 8.6M | 11.4M | 15.9M | 21.7M | ||
| Earnings Per Share | EPS | -$1.40 | -$1.65 | -$1.40 | -$1.79 | |
| EPS Diluted | -$1.40 | -$1.65 | -$1.40 | -$1.79 | ||
